Literature DB >> 19708855

Ketamine mouthwash for mucositis pain.

Andrew Joseph Ryan1, Faith Lin, Rabia Samady Atayee.   

Abstract

PURPOSE: Our objective was to determine if an oral ketamine swish and expectorate was a safe and effective method to alleviate mucositis pain.
METHODS: A retrospective chart audit was preformed on eight patients who received ketamine mouthwash (20 mg/5 mL) for refractory mucositis pain.
RESULTS: All eight patients had mucositis pain refractory to a mucositis mixture (lidocaine, magnesium/aluminum hydroxide, and diphenhydramine) and opioids. An improvement in mucositis pain was seen in over half (5/8) of the patients. Four of eight patients had adverse effects that could have been associated with the ketamine mouthwash; all side effects were transient and subsided when the ketamine mouthwash was stopped.
CONCLUSION: Ketamine swish and expectorate may be a viable treatment option in refractory mucositis pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19708855     DOI: 10.1089/jpm.2009.0198

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  7 in total

1.  Treatment of severe mucositis pain with oral ketamine mouthwash.

Authors:  Alexandra Shillingburg; Abraham S Kanate; Mehdi Hamadani; Sijin Wen; Michael Craig; Aaron Cumpston
Journal:  Support Care Cancer       Date:  2017-02-11       Impact factor: 3.603

Review 2.  [Topical pain therapy in oral mucositis: a systematic review].

Authors:  H Bornemann-Cimenti; S K Kobald; I S Szilagyi; A Sandner-Kiesling
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

Review 3.  Palliative dental care- a boon for debilitating.

Authors:  Bhavana Sujana Mulk; Raja Lakshmi Chintamaneni; Prabhat Mpv; Sarat Gummadapu; Shyam Sundar Salvadhi
Journal:  J Clin Diagn Res       Date:  2014-06-20

4.  New photobiomodulation protocol prevents oral mucositis in hematopoietic stem cell transplantation recipients-a retrospective study.

Authors:  Camila Weissheimer; Marina Curra; Lauro J Gregianin; Liane E Daudt; Vivian P Wagner; Marco Antonio T Martins; Manoela D Martins
Journal:  Lasers Med Sci       Date:  2017-08-24       Impact factor: 3.161

5.  Advancing Pharmacist Collaborative Care within Academic Health Systems.

Authors:  Linda Awdishu; Renu F Singh; Ila Saunders; Felix K Yam; Jan D Hirsch; Sarah Lorentz; Rabia S Atayee; Joseph D Ma; Shirley M Tsunoda; Jennifer Namba; Christina L Mnatzaganian; Nathan A Painter; Jonathan H Watanabe; Kelly C Lee; Charles D Daniels; Candis M Morello
Journal:  Pharmacy (Basel)       Date:  2019-10-11

6.  A novel lozenge containing bupivacaine as topical alleviation of oral mucositis pain in patients with head and neck cancer: a pilot study.

Authors:  Stine Mogensen; Charlotte Treldal; Kolbrún Sveinsdottir; Kenneth Jensen; Claus A Kristensen; Torben S Mogensen; Janne Petersen; Ove Andersen
Journal:  Pain Rep       Date:  2016-09-30

7.  Effect of bupivacaine lozenges on oral mucositis pain: a randomized controlled multicenter phase II study.

Authors:  Stine Mogensen; Charlotte Treldal; Claus A Kristensen; Jens Bentzen; Louise Lawson-Smith; Janne Petersen; Ove Andersen
Journal:  Pain Rep       Date:  2017-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.